. Author manuscript; available in PMC: 2015 Dec 16.

Published in final edited form as: Clin Exp Nephrol. 2015 Mar 21;19(6):1098–1106. doi: 10.1007/s10157-015-1106-2

Table 2.

Efficacy of spironolactone treatment adjusted by hemodynamic alterations

Variable	Estimate	SE	t	P
Intercept	−661.87	631.28	−1.05	0.3002
Spironolactone	−514.38	137.59	3.74	0.0005^*
Albuminuria (at entry)	−0.42	0.09	−4.44	< 0.0001^*
eGFR (at entry)	2.23	3.91	0.57	0.5727
eGFR [delta (8–0 week)]	2.4	6.13	0.39	0.6972
SBP (at entry)	3.24	4.09	0.79	0.4327
SBP [delta (8–0 week)]	1.87	2.57	0.73	0.4695

GFR glomerular filtration rate, SBP systolic blood pressure

P < 0.05